UniQure - Stock Price History | QURE

Historical daily share price chart and data for UniQure since 2021 adjusted for splits. The latest closing stock price for UniQure as of September 24, 2021 is 33.77.
  • The all-time high UniQure stock closing price was 82.19 on June 21, 2019.
  • The UniQure 52-week high stock price is 52.19, which is 54.5% above the current share price.
  • The UniQure 52-week low stock price is 25.80, which is 23.6% below the current share price.
  • The average UniQure stock price for the last 52 weeks is 35.57.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
UniQure Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 49.8212 70.2600 73.9700 35.3500 36.1300 -49.58%
2019 55.3367 28.5300 82.1900 27.3900 71.6600 148.65%
2018 29.7859 20.1600 43.0800 17.1000 28.8200 47.12%
2017 8.6833 5.8700 19.5900 4.8200 19.5900 249.82%
2016 10.3052 15.8100 18.2300 5.6000 5.6000 -66.14%
2015 23.7932 14.7100 33.6300 14.7100 16.5400 11.68%
2014 12.1273 14.6100 18.0500 8.6300 14.8100 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $1.657B $0.038B
UNIQURE B.V. is involved in developing gene therapy for patients of genetic or acquired diseases. It offers Glybera for the treatment of lipoprotein lipase deficiency, an orphan metabolic disease. The company's product pipeline includes which are in clinical trials are additional adeno-associated virus consist of AMT-060, AMT-021, AMT-110 and AAV2/glial. UNIQURE B.V. is headquartered in Amsterdam, the Netherlands.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $134.727B 8.97
Bio-Rad Laboratories (BIO.B) United States $23.483B 50.05
QIAGEN (QGEN) Netherlands $12.500B 21.17
Biohaven Pharmaceutical Holding (BHVN) United States $8.865B 0.00
Emergent Biosolutions (EBS) United States $2.891B 6.97
Arcus Biosciences (RCUS) United States $2.641B 0.00
Myovant Sciences (MYOV) United Kingdom $2.145B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.998B 0.00
Zymeworks (ZYME) Canada $1.380B 0.00
Ambrx Biopharma (AMAM) United States $0.521B 0.00
SQZ Biotechnologies (SQZ) United States $0.427B 0.00
Enzo Biochem (ENZ) United States $0.175B 51.71